Qube Research & Technologies (QRT)
MXCT icon

Qube Research & Technologies (QRT)’s MaxCyte MXCT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Buy
+389,102
New +$388K ﹤0.01% 2669
2025
Q4 		– Sell
-12,897
Closed -$20.4K – 3938
2025
Q3 		$20.4K Buy
+12,897
New +$22.4K ﹤0.01% 3290
2024
Q2 		– Sell
-17,535
Closed -$73.5K – 4427
2024
Q1 		$73.5K Buy
17,535
+11,690
+200% +$54.9K ﹤0.01% 3407
2023
Q4 		$27.5K Sell
5,845
-25,066
-81% -$97.6K ﹤0.01% 3433
2023
Q3 		$96.4K Buy
+30,911
New +$124K ﹤0.01% 2664
2022
Q3 		– Sell
-20,930
Closed -$99K – 2830
2022
Q2 		$99K Sell
20,930
-19,119
-48% -$94.2K ﹤0.01% 1955
2022
Q1 		$280K Buy
+40,049
New +$273K ﹤0.01% 1821

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MXCT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in MaxCyte (MXCT) in Q2 2026: 389,102 shares worth $479K. The stake represents ﹤0.01% of the portfolio and ranks #2669 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MXCT as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in MXCT in Q1 2022 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 389,102 shares of MaxCyte worth $479K as of Q2 2026.
  • MaxCyte was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2669 holding.
  • Qube Research & Technologies (QRT) first reported a position in MaxCyte in Q1 2022 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.